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Abstract
Background: Domestic dogs and cats are very well known to develop chronic hepatic diseases, including hepatic
lipidosis and cirrhosis. Ultrasonographic examination is extensively used to detect them. However, there are still
few reports on the use of the ultrasound B-mode scan in correlation with histological findings to evaluate diffuse
hepatic changes in rodents, which represent the most important animal group used in experimental models of
liver diseases. The purpose of this study was to determine the reliability of ultrasound findings in the assessment of
fatty liver disease and cirrhosis when compared to histological results in Wistar rats by following up a murine
model of chronic hepatic disease.
Results: Forty Wistar rats (30 treated, 10 controls) were included. Liver injury was induced by dual exposure to CCl4
and ethanol for 4, 8 and 15 weeks. Liver echogenicity, its correlation to the right renal cortex echogenicity,
measurement of portal vein diameter (PVD) and the presence of ascites were evaluated and compared to
histological findings of hepatic steatosis and cirrhosis. Liver echogenicity correlated to hepatic steatosis when it
was greater or equal to the right renal cortex echogenicity, with a sensitivity of 90%, specificity of 100%, positive
and negative predictive values of 100% and 76.9% respectively, and accuracy of 92.5%. Findings of heterogeneous
liver echogenicity and irregular surface correlated to liver cirrhosis with a sensitivity of 70.6%, specificity of 100%,
positive and negative predictive values of 100% and 82.1% respectively, and accuracy of 87.5%. PVD was
significantly increased in both steatotic and cirrhotic rats; however, the later had greater diameters. PVD cut-off
point separating steatosis from cirrhosis was 2.1 mm (sensitivity of 100% and specificity of 90.5%). One third of
cirrhotic rats presented with ascites.
Conclusion: The use of ultrasound imaging in the follow-up of murine diffuse liver disease models is feasible and
efficient, especially when the studied parameters are used in combination. The potential implication of this study is
to provide a non-invasive method that allows follow-up studies of fatty liver disease and cirrhosis of individual rats
for pre-clinical drug or cell based therapies.
Background
Domestic dogs and cats are very well known to
develop chronic hepatic diseases. Hepatic lipidosis
(HL) or fatty liver is an important liver disease in cats.
It is characterized by excess fat accumulation in the
liver and seems to have no age, breed, or gender predi-
lection [1,2]. HL is more common in obese or pre-
viously obese cats which have undergone brief periods
of anorexia or food deprivation [3]. Obesity in cats has
been described as the most prevalent nutritional dis-
ease of the domestic cat in the United States of Amer-
ica [4]. Cornelius and DeNovo [5] reported HL as the
underlying disease process in 12.5% of 80 cats with
icterus.
Chronic hepatitis is a well-recognized problem in
canine practice and affects dogs of many breeds [6].
However, knowledge of its etiology in dogs remains
limited [7]. If chronic hepatitis is not treated, it can
lead to the development of liver cirrhosis, which is
characterized by architectural distortion of lobules,
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sis [7].
Murine models of diffuse liver disease can be used as
a base for pre-clinical studies [8]. Radiological methods
such as ultrasound (US) brightness-mode (B-mode) ima-
ging [1,2,9-11], duplex Doppler US [12], computed
tomography perfusion [13] and magnetic resonance ima-
ging (MRI) [14,15] have been used to detect and to fol-
low-up experimental diffuse liver disease models.
Additionally, Quintanilha et al [16] utilized US B-mode
imaging in a longitudinal stu d yt of o l l o w - u pt h ee f f e c t s
of bone marrow stem cell therapy in rats submitted to
liver injury, while Ju et al [17] prospectively tracked
stem cells labeled with super paramagnetic particles
transplanted intrasplenically in cirrhotic rats by MRI.
US examination has been extensively used to detect
fatty liver disease and cirrhosis [18-20]. In cats and
dogs, fatty liver disease can be diagnosed by the obser-
vation of an increased hepatic echogenicity, character-
ized by hyperechoic liver parenchymal texture
compared to the renal cortex, and decreased visualiza-
tion of deeper structures, such as the diaphragm and
small peripheral vessels [21,22]. Cirrhosis, on the other
hand, can be detected by a coarse and heterogeneous
parenchymal echogenicity, irregular or nodular liver
surface [21-23], focal regenerative nodules [21,24],
decreased right lobe to caudate lobe ratio, indicating
volume redistribution [25], and by indirect evidence of
portal hypertension, such as increased portal vein dia-
meter (PVD), presence of collateral vessels, splenome-
galy and ascites [21,23,26].
Even though there are a number of studies that use
US B-mode to evaluate liver diseases in rodents
[9,27,28], few of these studies have statistically corre-
lated US findings to the histological alterations present
in liver parenchyma [29-31]. Lee et al [29] compared
histopathological findings to the US B-mode quantitative
parameter Mean Grey Level in CCl4-induced liver cir-
rhosis, while Matsuhashi et al [30] and Layer et al [31]
correlated histology to Hepatic Ultrasound Speed and
Texture Analysis respectively.
However, regardless of the fact that there is a correlation
between quantitative B-mode methods and the histological
features of cirrhosis, qualitative ultrasonography, which is
the most common evaluation method of liver diseases in
clinical practice both in animals and in humans, remains
to be validated as a technique for the non-invasive diagno-
sis of such diseases in rodents. The purpose of our study
was to determine the reliability of US qualitative findings
in the assessment of fatty liver disease and cirrhosis in
Wistar rats in comparison to histological results by follow-
ing up a murine model of hepatic disease induced by dual
exposure to CCl4 and ethanol.
Methods
Animals
This investigation was performed in agreement with the
Guide for Care and Use of Laboratory Animals [DHHS
Publication No. (NIH) 85-23, revised 1996, Office of
Science and Health Reports, Bethesda, MD 20892] and
the authors have received approval from the Institu-
tional Animal Care and Use Committee (protocol #021).
Female Wistar rats with 6 - 12 months of age, weighing
between 160 - 180 g were housed at controlled tempera-
ture (23°C) with daily exposure to a 12:12 light-dark cycle.
Model of Experimental Cirrhosis
Animals (n = 40) were randomly divided into two groups:
the Control group (n = 10) was fed with standard rat
chow and water, and the Experimental group (n = 30)
had chronic liver damage induced according to the pro-
tocol previously described by Dias et al [10], Quintanilha
et al [16] and Carvalho et al [32]. Briefly, liver damage
was induced with injections of a 20% solution of carbon
tetrachloride (CCl4) (1:5 in olive oil, dose of 0.05 mL/kg)
intraperitoneally three times a week on alternate days
combined with an alcoholic liquid diet in accordance
with the AIN-93 guidelines [33] over 15 weeks.
Ultrasound Analysis
The Control and the Experimental groups were exam-
ined at the beginning of the experiment and after 4, 8
and 15 weeks of liver injury induction. Animals were
anesthetized using ketamine (0.5 mL/kg) and xilazin
(1 mL/kg) and had the abdomen shaved to reduce ima-
ging artifacts in the ultrasonographic examination.
A sound-conducting gel (Carbogel®, Brazil) was applied
and an US examination was performed by two blinded
expertise authors by consensus (reader 1, A.S.L., with 7
years experience, reader 10, C.M.C.R., with 26 years
experience) by using a multifrequency linear transducer
(7.5 to 10 MHz) and a Caris Plus® ultrasound equipment
(Esaote, Italy). All imaging was performed in fundamen-
tal brightness mode (B-mode). Two-dimensional B-
mode image plans were acquired with optimization of
the gain and the time gain compensation settings, which
were kept constant throughout the experiment. The
acoustic focus was placed in the center of the target
organ (liver) and in the largest transverse cross section
of the spleen. The animals were examined in supine
position to assess the liver and the portal vein, and in
the right posterior oblique position to assess the spleen.
These organs were evaluated by multiple transversal and
longitudinal scans.
Ultrasonographic findings were analyzed based on our
previous observations and on criteria for US diagnosis
in humans according to the following classification:
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Page 2 of 10A. Changes in the liver echogenicity, classified into
four patterns: (1) homogeneous liver parenchyma with
medium level echogenicity and a regular hepatic sur-
face; (2) diffusely increased parenchymal echogenicity,
reduced visualization of the diaphragm and small
peripheral vessels in the liver with no change on liver
surface; (3) discrete coarse and heterogeneous parench-
ymal echogenicity, dotted or slightly irregular liver
surface; (4) extensive coarse and heterogeneous par-
enchymal echogenicity, irregular or nodular hepatic
surface reflecting the presence of underlying regenera-
tive nodules;
B. Inversion of the echographic relationship between the
liver and the renal cortex. This finding was considered
to be positive if the echogenicity of the liver parenchyma
was greater or equal to that of the right renal cortex;
C. Increased PVD. It was measured in the mid-point of
the main portal vein by using calipers of the scanner.
PVD was considered to be abnormal if equal or greater
than 2.1 mm;
D. Presence of ascites;
E. Spleen area. It was directly calculated by the US soft-
ware after organ surface was delineated by the examiner.
Histological analysis
Rats from the Experimental and Control Groups were
sacrificed on the 4
th (n = 6), 8
th (n = 7) and 15
th (n =
17) week of the cirrhosis induction protocol. The liver
was removed from the abdominal cavity for macroscopic
post mortem analysis. For microscopic examination,
liver tissue was fixed for 5 h in Gendre’s solution fol-
lowed by overnight incubation in 10% buffered formalin
solution (pH 7.2) and embedded in paraffin. Liver sam-
ples were sectioned (5 μm) and stained with hematoxilin
a n de o s i n( H & E )[ 3 4 ]o rS i r i u sR e d[ 3 5 ]a c c o r d i n gt o
standard protocols.
The histological diagnosis of fatty liver disease and cir-
rhosis was defined by a single blinded experienced
pathologist based on the hepatic steatosis grading estab-
lished by Ishak et al [36] and on the scoring system for
hepatic fibrosis described by Plummer et al [37], respec-
tively. Histology was used as the gold standard for both
the diagnosis of fatty liver disease and cirrhosis and for
the comparison with US results.
Statistical Analysis
The sensitivity, specificity, positive predictive value,
negative predictive value and accuracy of the US find-
ings for the detection of fatty liver disease and cirrhosis
were calculated in comparison to the histological diag-
nosis [38]. PVD values were analyzed using analysis of
variance (ANOVA) with Tukey’s post-test for multiple
comparisons. The value of p < 0.01 was considered sta-
tistically significant. Data are presented as mean ± SD.
We also performed a Receiver Operating Characteristic
(ROC) analysis of these data.
Results
Ultrasound Imaging
All animals were examined by US imaging in the begin-
ning of experiment and after 4, 8 and 15 weeks of liver
injury induction and the alterations found in the Experi-
mental group were homogeneous in each examination
time point. These alterations were represented by
changes in liver echogenicity, in the relationship
between liver parenchyma and renal cortex echogenicity,
increased values of PVD and higher incidence of ascites
when compared to the Control group (Table 1). A sub-
set of animals in the Experimental group was sacrificed
after 4 (n = 6) and 8 (n = 7) weeks of liver injury induc-
tion for histological studies, while the remaining animals
(n = 17) were sacrificed after 15 weeks.
Histological Analysis
Control group showed a normal architecture with hepa-
tocytes radially arranged in plates aligned to sinusoids
converging to centrolobular veins and without evidence
of fibrosis (Figure 1a). On the other hand, the Experi-
mental group showed liver parenchymal alterations that
correlated to the time of injury induction. After 4 weeks
(n = 6), half of the animals presented with mild steatosis
without fibrous septa and the other half showed mild to
moderate steatosis with minimal focal pericellular and
perivenular fibrosis (Figure 1b). After 8 weeks (n = 7),
all the animals showed moderate to marked steatosis
with some fibrous septa linking centrolobular veins to
portal tracts, although liver parenchymal architecture
was preserved (Figure 1c). After 15 weeks of induction
(n = 17), all rats had macronodular cirrhosis, character-
ized by global architectural distortion and formation of
regenerative nodules surrounded by collagen septa and
containing some inflammatory infiltrate (Figure 1d).
Mild to moderate steatosis was also present.
The prevalence of fatty liver disease among the 30 rats
in the Experimental group was 100%, while the prevalence
of cirrhosis was 56.7% (17 out of 30) when considering all
the time points examined together. The lower prevalence
of cirrhosis is expected since animals take longer periods
of time to fully develop the histological alterations found
in this disease. Accordingly, if we consider only the subset
of animals that were injured for 15 weeks, the prevalence
of cirrhosis was also 100%. No animals in the Control
group presented with fatty liver disease or cirrhosis.
Correlation between Ultrasound Findings and
Histological Diagnosis
Ultrasound and histological findings among the experi-
mental groups were compared in the different time
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Page 3 of 10points (Table 2, Figure 2). Samples of acquired US data
used to perform correlation analysis can be seen in addi-
tional files (additional file 1, 2, 3, 4 and 5)
Liver echogenicity
The increase in liver echogenicity compared to right
renal cortex echogenicity (L-Echo ≥ R-Echo) had a sen-
sitivity of 90% (27 out of 30), specificity of 100% (10 out
of 10), positive predictive value of 100% (27 out of 27),
negative predictive value of 76.9% (10 out of 13) and
accuracy of 92.5% (37 out of 40) for the detection of
fatty liver disease and were well correlated with patterns
2 and 3 of liver echogenicity. The 3 rats which appeared
to be normal in ultrasound imaging showed mild steato-
sis in microscopy. Control animals were all classified as
pattern 1 and presented with normal liver parenchyma.
Moreover, pattern 4, characterized by extensive coarse
and heterogeneous parenchymal echogenicity and irregu-
lar or nodular hepatic surface, was always associated with
alteration of the echographic relationship between the
liver and the right renal cortex. It had a sensitivity of
70.6% (12 out of 17), specificity of 100% (23 out of 23),
positive predictive value of 100% (12 out of 12), negative
Figure 1 Histological findings observed over the experiment. (a) Microscopy of Control group (normal liver): Hematoxilin/Eosin (H&E) section
(magnification 100×) shows hepatocytes radially arranged in plates aligned to sinusoids (arrowheads). Sirius red (magnification 100×) staining
shows only vessels stained in red (portal triad - PT), which is a normal place of collagen deposit. (b) After 4 weeks of experiment: H&E section
(magnification 100×) shows moderate steatosis (arrows). Sirius red (magnification 100×) staining shows focal perivenular and pericellular fibrosis
(arrowheads). (c) After 8 weeks of experiment H&E section (magnification 100×) shows moderate steatosis (arrows) with some fibrosis
(arrowheads) but preserved liver parenchymal architecture. Sirius red (magnification 100×) staining some fibrous septa linking centrolobular veins
with portal tracts (arrowheads). (d) After 15 weeks of protocol: H&E section (magnification 100×) shows macronodular cirrhosis, characterized by
thick collagen septa, forming regenerative nodules, global architectural distortion, some inflammatory infiltrate (arrow) and steatosis. Sirius red
(magnification 100×) staining shows thick collagen septa (arrowheads) linking portal tracts, centrolobular veins, and portal tracts to centrolobular
veins, forming regenerative nodules (RN).
Table 1 Ultrasound findings over the time of experiment observed in Experimental group compared to Control group
US findings/Time of experiment Control Group
at any time
(n = 10)
Experimental Group
4 weeks
(n = 6)
8 weeks
(n = 7)
15 weeks
(n = 17)
Homogeneous liver parenchyma of medium level echogenicity (pattern 1) 10 3 0 0
Diffusely increased parenchymal echogenicity (pattern 2) 0 3 3 0
Discrete coarsened and heterogeneous parenchyma (pattern 3) 0 0 4 5
Extensive coarsened and heterogeneous parenchyma (pattern 4) 0 0 0 12
L-Echo<R-Echo 10 3 0 0
L-Echo=R-Echo 0 2 4 8
L-Echo>R-Echo 0 1 3 9
Liver isoechoic nodule 0 0 0 2
Liver hypoechoic nodule 0 0 0 1
PVD< 2.1 mm 10 6 6 0
PVD ≥ 2.1 mm 0 0 1 17
Mild or transient ascites 0 0 0 2
Moderate or marked ascites 0 0 0 3
PVD: Portal Vein Diameter; L-Echo: Liver echogenicity; R-Echo: Renal cortex echogenicity.
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87.5% (35 out of 40) for the detection of liver cirrhosis.
Portal Vein Diameter (PVD)
In the Experimental group, portal vein became wider
and tortuous during hepatic disease development when
compared to Control group (Figure 3). We analyzed
PVD values among rats with cirrhosis, rats with steatosis
and fibrosis and rats from the Control group. The
results found were 2.2 ± 0.2 mm, 1.8 ± 0.2 mm and 1.5
± 0.2 mm, respectively. PVD was significantly higher in
cirrhotic rats and in rats with steatosis and fibrosis in
comparison to the Control group (Figure 4), suggesting
the presence of portal hypertension.
After Receiver Operating Characteristic (ROC) analysis
of these data (Figure 5), we found that PVD values equal
or greater than 2.1 mm had sensitivity of 100%, specifi-
city of 90.5%, positive predictive value of 89.5% and
negative predictive value of 100% for the detection of
cirrhosis. Thus, this value can be considered a cut-off
point for the diagnosis of cirrhosis in rats.
Presence of ascites and spleen measurements
Furthermore, the occurrence of ascites could be easily
identified, even when small quantities of fluid were pre-
sent in the abdominal cavity. This alteration was
observed in 5 out of 17 cirrhotic rats (34%).
We also compared the spleen area among rats with
cirrhosis, rats with steatosis and fibrosis and rats from
t h eC o n t r o lg r o u p .T h er e s u l t sf o u n dw e r e1 . 1 9±0 . 1 6
cm
2,1 . 1 6±0 . 1 4c m
2 and 1.18 ± 0.16 cm
2, respectively.
There were no statistical differences among the three
groups analyzed, indicating that splenomegaly was not a
prominent feature in cirrhotic rats.
Discussion
In this work we demonstrated that qualitative ultrasound
analysis is sensitive and specific enough to diagnose fatty
liver disease and cirrhosis in rats and, therefore, can reliably
substitute histological diagnosis in experimental liver dis-
ease models. Ultrasound imaging has many advantages,
namely its low cost, extensive availability and the fact that it
can be easily done in murine models. Only slight sedation
and abdominal shaving are required, not demanding total
immobility or apnea while obtaining the images [39], there-
fore, consisting in a low risk procedure. Moreover, it is an
accurate, innocuous and non-invasive technique and it is
the most commonly used method for the investigation of
liver diseases in humans and small animals [1,18-21,40,41].
Although ultrasound is an essentially subjective diag-
nostic method, its validity as an imaging technique for
liver evaluation has been extensively described in the lit-
erature for humans [40,42], dogs [21-23] and cats [1,21].
In our study, we focused our attention in a rodent
model of liver disease, since these are the most com-
monly used models in pre-clinical studies [37,43-46].
The rat model was chosen because they are larger than
mice, facilitating US imaging procedure.
Table 2 Ultrasound findings compared to histological diagnosis
Histologic Diagnosis
US findings Normal (n = 10) Mild steatosis
without fibrous
septa (n = 3)
Mild to marked hepatic
steatosis with various
degrees of fibrosis but
intact liver parenchymal
architecture (n = 10)
Macronodular cirrhosis
with hepatic
steatosis (n = 17)
Pattern 1 L-Echo
L-Echo < R-Echo
10 3 0 0
Pattern 1 L-Echo
L-Echo ≥ R-Echo
00 0 0
Pattern 2, 3 or 4 L-Echo
L-Echo < R-Echo
00 0 0
Pattern 2 L-Echo
L-Echo ≥ R-Echo
00 6 0
Pattern 3 L-Echo
L-Echo ≥ R-Echo
00 4 5
Pattern 4 L-Echo
L-Echo ≥ R-Echo
00 0 1 2
Liver nodules 0 0 0 3 (regenerative nodules)
PVD < 2.1 mm 10 3 9 0
PVD ≥ 2.1 mm 0 0 1 17
Presence of ascites 0 0 0 5
L-Echo: Liver echogenicity; Pattern 1: normal echogenicity, pattern 2: diffusely increased echogenicity, pattern 3: slightly coarse echogenicity, and pattern 4:
coarse and heterogeneous echogenicity; R-Echo: Renal cortex echogenicity; PVD: Portal Vein Diameter.
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with medium level echogenicity and regular liver sur-
face, as previously described in humans [47], dogs
[21,23,48] and cats [2,21]. Liver echogenicity was lower
in comparison to the right renal cortex, a finding that
contrasts with humans [47], but is in accordance to
what has been described in dogs [49]. In cats, renal cor-
tical echogenicity varies in normal animals [50]. Fatty
liver disease in rats was characterized by homogeneous
and diffusely increased echogenicity ("bright liver”),
equal or greater to the right renal cortex, reduced visua-
lization of the diaphragm and of small peripheral ves-
sels, and by no changes in liver surface, as described in
humans [51], dogs [21,23], and cats [1,21].
Liver echogenicity increases due to the presence of
fatty infiltration and/or fibrosis [21,23], changing the
Figure 3 Portal vein widening over the experiment.( a )
Parasagittal sonogram shows a straight and thin portal vein
(diameter = 1.5 mm) in a Control group rat (arrowheads). (b)
Parasagittal sonogram demonstrates a slightly tortuous and thin
portal vein (diameter = 2.0 mm) in a rat with hepatic steatosis and
fibrosis (arrowheads). (c) Parasagittal sonogram presents a tortuous
and wide portal vein (diameter = 2.4 mm) in a cirrhotic rat
(arrowheads).
Figure 2 Correlation between ultrasound and histological findings. (a) Sonograms and macroscopy of Control group (normal liver):
Transversal sonogram demonstrates homogeneous liver parenchyma, with medium level echogenicity and a regular hepatic surface
(arrowheads). Parasagittal sonogram presents right renal cortex more echogenic than liver. Macroscopy shows smooth surface, brownish-red
color and friable consistency. (b) Sonograms and macroscopy of fatty liver: Transversal sonogram presents diffusely increased parenchymal
echogenicity. Parasagittal sonogram demonstrates hepatic echogenicity greater than that of right renal cortex. Macroscopy exhibits wrinkled
surface, yellowish color and friable consistency. (c) Sonograms and macroscopy of liver carrying steatosis and fibrosis: Transversal sonogram
shows discrete coarse and heterogeneous parenchymal echogenicity and the liver surface as a dotted or slightly irregular line (arrowheads).
Parasagittal sonogram presents hepatic echogenicity equal to the right renal cortex echogenicity and a slightly irregular liver surface (arrowhead).
Macroscopy shows a slightly irregular surface, pale red color and more rigid consistency. (d) Sonograms and macroscopy of cirrhotic liver:
Transversal sonogram presents extensive coarse and heterogeneous parenchymal echogenicity, extremely irregular hepatic surface (arrowheads),
a hypoechoic regenerative nodule (arrow) and mild ascites (*). Parasagittal sonogram shows hepatic echogenicity slightly greater than that of
the right renal cortex, extremely irregular liver surface (arrowhead) and mild ascites (*). Macroscopy reveals extremely irregular surface, reflecting
the presence of underling regenerative nodules, reddish color and rigid consistency.
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city [21,22]. This finding had high sensitivity (90%), spe-
cificity (100%), positive and negative predictive values
(100% and 76.9%), and accuracy (92.5%) for the detec-
tion of fatty liver disease, values that were compatible
with the ones previously described in the literature. The
increased liver echogenicity has been reported to have
s e n s i t i v i t yo f6 0t o8 2 %[ 1 , 2 3 , 5 2 ] ,s p e c i f i c i t yo f9 7t o
100% [1,52] and positive predictive value of 96 to 100%
[1,52] for detection of fatty liver disease. However, it is
important to exclude kidney diseases when utilizing this
approach [23].
Three rats with mild hepatic steatosis appeared to be
normal in US examination, which is also comparable to
previous reports in the literature [23,52]. US has been
reported to have sensitivity of 90 - 91% for the detection
of moderate to marked steatosis, but its sensitivity
decreases to 30 - 64% when steatosis is mild [23,52].
The finding of an extensive coarse and heterogeneous
parenchyma associated to irregular or nodular hepatic
surface proved to be relevant in the detection of
Figure 4 Comparison between portal vein diameter and
histological findings. Quantification of portal vein diameter shows
increase in this value in the group of cirrhotic rats (mean = 2.2 mm)
and in the group of rodents with steatosis and fibrosis (mean = 1.8
mm) compared to the Control group (mean = 1.5 mm). Data are
shown as mean ± SD and the test utilized was ANOVA with the
Tukey’s post-test for multiple comparisons.
Figure 5 ROC (Receiver Operating Characteristic) analysis of Portal Vein Diameter (PVD) values.
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positive predictive value of 100%, negative predictive
value of 82.1% and accuracy of 87.5%, as seen in
humans [40,53] and in dogs [23]. Its presence implied a
definitive diagnosis of cirrhosis since there were no false
negative results. Therefore, US imaging can consistently
substitute histology to diagnose cirrhosis in rats, consti-
tuting a useful method to avoid unnecessary animal
sacrifice or repeated liver biopsies when following long
experimental protocols.
The evaluation of portal hypertension is also impor-
tant to assess the severity of liver diseases [20,21,40] and
one of its most important signs is the widening of the
portal vein [20,21,47]. PVD was statistically different
when comparing cirrhotic to non-cirrhotic rats (p <
0.001). An increase in its caliber when equal or superior
to 2.1 mm can be considered a relevant ultrasound find-
ing with sensitivity of 100%, specificity of 90.5%, positive
predictive value of 89.5% and negative predictive value
of 100% for the detection of cirrhosis. There was one
false positive, a rat bearing liver steatosis with fibrosis.
There were no false negatives since none of the rats
with PVD lower than 2.1 mm were cirrhotic. Addition-
ally, PVD measurements were unable to distinguish nor-
mal from steatotic livers because of the considerable
overlap between PVD values encountered in normal rats
compared to rats carrying steatosis and fibrosis. This
fact is, nonetheless, expected since fatty liver disease
does not lead to portal hypertension and, consequently,
to the widening of the portal vein. Doppler evaluation of
the portal vein was also tried, yet it was not possible
due to technical difficulties. The caliper could not be
stably positioned inside such a small vessel, we could
not induce apnea and whirl flow was found even in nor-
mal rats, causing an oscillation between hepatopetal and
hepatofugal flow.
The presence of ascites, which is also an important
indicator of the severity of liver disease, could be
detected even when the amount of fluid present in the
peritoneal cavity was small, as previously reported by
Vörös et al [54]. Among the imaging diagnostic meth-
ods, ultrasound is considered ideal for the study of
ascites [6,21,23]. In our study, its presence invariably
corresponded to cirrhosis in histology, although only 5
animals presented with ascites out of 17 cirrhotic rats.
This was, however, expected since ascites is only
observed when cirrhosis is decompensated. In addition,
although splenomegaly should be expected in severe cir-
rhosis with portal hypertension, there were no statistical
differences in splenic area among the three groups ana-
lyzed, indicating that splenomegaly was not a prominent
feature in our study of cirrhotic rats.
Conclusion
The use of ultrasound imaging in the diagnosis of mur-
ine liver disease models is feasible and efficient, espe-
cially when different parameters (liver echogenicity and
its correlation to that of the right renal cortex, PVD and
t h ep r e s e n c eo fa s c i t e s )a r eused in combination. The
implication of this study is to certify that fatty liver dis-
ease and cirrhosis can be reliably diagnosed by a non-
invasive method that allows adequate long-term follow-
up, which is usually needed in pre-clinical drug or cell-
based therapy studies.
Additional file 1: Ultrasound imaging of Control group (transversal
and parasagittal views). The exam begins making transversal scanning,
which shows homogeneous liver parenchyma, with medium level
echogenicity and a regular hepatic surface. In the sequence, the
parasagittal scanning shows right renal cortex more echogenic than liver.
Author: Lessa AS. Length: 31 seconds. Size: 2.65 MB.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1746-6148-6-6-
S1.MPG]
Additional file 2: Ultrasound imaging of steatotic liver (transversal
view). Transversal scanning shows diffusely increased parenchymal
echogenicity. Author: Lessa AS. Length: 35 seconds. Size: 3.02 MB.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1746-6148-6-6-
S2.MPG]
Additional file 3: Ultrasound imaging of steatotic liver (parasagittal
view). Parasagittal sacanning shows hepatic echogenicity slightly greater
than that of right renal cortex. Author: Lessa AS. Length: 10 seconds. Size:
0.39 MB.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1746-6148-6-6-
S3.MPG]
Additional file 4: Ultrasound imaging of cirrhotic liver (transversal
view). Transversal scanning shows marked ascites, extensive coarse and
heterogeneous parenchymal echogenicity and extremely irregular
hepatic surface. Author: Resende CMC. Length: 35 seconds. Size: 3.06 MB.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1746-6148-6-6-
S4.MPG]
Additional file 5: Ultrasound imaging of cirrhotic liver (parasagittal
view). Parasagittal scanning shows hepatic echogenicity equal to that of
the right renal cortex, extremely irregular liver surface, tortuous and wide
portal vein and marked ascites. Author: Resende CMC. Length: 70
seconds. Size: 6.06 MB.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1746-6148-6-6-
S5.MPG]
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